Literature DB >> 5574520

Duchenne muscular dystrophy: functional ischemia reproduces its characteristic lesions.

J R Mendell, W K Engel, E C Derrer.   

Abstract

The highly characteristic early and midstage histological lesions of Duchenne dystrophy were reproduced experimentally in the rat by the combination of a vascular abnormality, aortic ligation, which does not affect the structure of the intramuscular blood vessels, and the humoral vasoactive substance 5-hydroxytryptamine. Neither ligation nor injection of 5-hydroxytryptamine alone causes changes in the muscle fibers. This result establishes the possibility of a similar combined mechanism for a nonstructural ischemia pathogenesis in Duchenne dystrophy. The proposed pathogenesis is contrary to the generally held idea that the cause is an intrinsic abnormality of muscle fiber metabolism.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5574520     DOI: 10.1126/science.172.3988.1143

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  40 in total

Review 1.  Neuromuscular disorders in childhood. Old dogmas, new concepts.

Authors:  V Dubowitz
Journal:  Arch Dis Child       Date:  1975-05       Impact factor: 3.791

2.  Dipeptidyl peptidases in the soleus muscle of the rat before and after treatment with 5-hydroxytryptamine.

Authors:  P J Stoward; K N Christie; C Thomson
Journal:  Histochemistry       Date:  1988

3.  Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy.

Authors:  Trent A Waugh; Eric Horstick; Junguk Hur; Samuel W Jackson; Ann E Davidson; Xingli Li; James J Dowling
Journal:  Hum Mol Genet       Date:  2014-04-23       Impact factor: 6.150

4.  Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin.

Authors:  Dejia Li; Akshay Bareja; Luke Judge; Yongping Yue; Yi Lai; Rebecca Fairclough; Kay E Davies; Jeffrey S Chamberlain; Dongsheng Duan
Journal:  J Cell Sci       Date:  2010-05-18       Impact factor: 5.285

Review 5.  Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.

Authors:  Joe N Kornegay; Christopher F Spurney; Peter P Nghiem; Candice L Brinkmeyer-Langford; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  ILAR J       Date:  2014

6.  Chronic hypoxia impairs muscle function in the Drosophila model of Duchenne's muscular dystrophy (DMD).

Authors:  Matias Mosqueira; Gabriel Willmann; Hannele Ruohola-Baker; Tejvir S Khurana
Journal:  PLoS One       Date:  2010-10-20       Impact factor: 3.240

7.  Inhibition of prostaglandin D synthase suppresses muscular necrosis.

Authors:  Ikuko Mohri; Kosuke Aritake; Hidetoshi Taniguchi; Yo Sato; Shinya Kamauchi; Nanae Nagata; Toshihiko Maruyama; Masako Taniike; Yoshihiro Urade
Journal:  Am J Pathol       Date:  2009-04-09       Impact factor: 4.307

8.  Synaptogenesis in cell cultures of neurones and myotubes from chickens with muscular dystrophy.

Authors:  J H Peacock; P G Nelson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-06       Impact factor: 10.154

9.  Nerve, muscle, and serotonin.

Authors:  M Takamori
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-01       Impact factor: 10.154

Review 10.  Alterations in mitochondrial function as a harbinger of cardiomyopathy: lessons from the dystrophic heart.

Authors:  Yan Burelle; Maya Khairallah; Alexis Ascah; Bruce G Allen; Christian F Deschepper; Basil J Petrof; Christine Des Rosiers
Journal:  J Mol Cell Cardiol       Date:  2009-09-18       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.